Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ptosis and bulbar onset: an unusual phenotype of familial ALS?
De Marchi F, Corrado L, Bersano E, Sarnelli MF, Solara V, D'Alfonso S, Cantello R, Mazzini L. De Marchi F, et al. Among authors: mazzini l. Neurol Sci. 2018 Feb;39(2):377-378. doi: 10.1007/s10072-017-3186-0. Epub 2017 Nov 13. Neurol Sci. 2018. PMID: 29134445
A case of late-onset OCD developing PLS and FTD.
Bersano E, Sarnelli MF, Solara V, De Marchi F, Sacchetti GM, Stecco A, Corrado L, D'alfonso S, Cantello R, Mazzini L. Bersano E, et al. Among authors: mazzini l. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):463-465. doi: 10.1080/21678421.2018.1440405. Epub 2018 Feb 16. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29451027
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases.
Corrado L, Tiloca C, Locci C, Bagarotti A, Hamzeiy H, Colombrita C, De Marchi F, Barizzone N, Cotella D, Ticozzi N, Mazzini L, Nazli Basak A, Ratti A, Silani V, D'alfonso S. Corrado L, et al. Among authors: mazzini l. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):426-431. doi: 10.1080/21678421.2018.1440407. Epub 2018 Feb 28. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29490503
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium; Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium; Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium; Gitler AD, Harris T, Myers RM; NYGC ALS Consortium; Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation; Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium; Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium; Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium; Corcia P… See abstract for full author list ➔ Nicolas A, et al. Among authors: mazzini l. Neuron. 2018 Mar 21;97(6):1267-1288. doi: 10.1016/j.neuron.2018.02.027. Neuron. 2018. PMID: 29566793 Free PMC article.
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies.
Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M, Aloisio I, Cionci NB, Gaggìa F, Lucenti A, Bersano E, Cantello R, Di Gioia D, Mogna G. Mazzini L, et al. J Clin Gastroenterol. 2018 Nov/Dec;52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S68-S70. doi: 10.1097/MCG.0000000000001042. J Clin Gastroenterol. 2018. PMID: 29782468 Clinical Trial.
Advances in stem cell therapy for amyotrophic lateral sclerosis.
Mazzini L, Ferrari D, Andjus PR, Buzanska L, Cantello R, De Marchi F, Gelati M, Giniatullin R, Glover JC, Grilli M, Kozlova EN, Maioli M, Mitrečić D, Pivoriunas A, Sanchez-Pernaute R, Sarnowska A, Vescovi AL; BIONECA COST ACTION WG Neurology. Mazzini L, et al. Expert Opin Biol Ther. 2018 Aug;18(8):865-881. doi: 10.1080/14712598.2018.1503248. Expert Opin Biol Ther. 2018. PMID: 30025485 Review.
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome.
Mazzini L, Gelati M, Profico DC, Sorarù G, Ferrari D, Copetti M, Muzi G, Ricciolini C, Carletti S, Giorgi C, Spera C, Frondizi D, Masiero S, Stecco A, Cisari C, Bersano E, De Marchi F, Sarnelli MF, Querin G, Cantello R, Petruzzelli F, Maglione A, Zalfa C, Binda E, Visioli A, Trombetta D, Torres B, Bernardini L, Gaiani A, Massara M, Paolucci S, Boulis NM, Vescovi AL; ALS-NSCs Trial Study Group. Mazzini L, et al. Stem Cells Transl Med. 2019 Sep;8(9):887-897. doi: 10.1002/sctm.18-0154. Epub 2019 May 18. Stem Cells Transl Med. 2019. PMID: 31104357 Free PMC article. Clinical Trial.
234 results